Basic Science News at Duke School of Medicine

Joseph Heitman, MD, PhD, has received the Lucille Georg Award in the basic scientist category from the International Society of Human and Animal Mycoses (ISHAM). This distinguished award recognizes lifetime achievements and outstanding contributions to the field of medical mycology.

If 98.8% of our DNA is the same as that of a chimpanzee, what changes in the remaining 1.2% make us human?

Study led by Duke School of Medicine reveals cancer’s weak spot – a protein that helps cells make energy and stops cancer from growing.

A new, high-resolution atlas of the mouse brain will increase precision in measuring changes in brain structure and make it easier to share results for scientists working to understand neurological diseases such as Alzheimer's.

A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

When Hurricane Helene hit Western North Carolina, it left more than flood damage—it created fertile ground for mold and fungus to growth. Now, a Duke University team is studying how post-disaster fungi could affect health and recovery in a warming world.

A multi-faceted study from Duke University School of Medicine researchers shows for the first time that blocking an under-studied enzyme called PKN2 may be the key to stopping aggressive, treatment-resistant cancers.

A proposed cap on National Institutes of Health funding could cost Duke University millions and stall critical breakthroughs -- like Laurie Sanders's blood test for early Parkinson's disease.